Insights

Patient Engagement – What History Teaches Us About Pharma’s Future Evolution

The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...

Monoclonal Antibodies Offer Much Needed Protection for the Immunocompromised Population

Even though we don’t feel it or notice it, each minute, our bodies’ immune systems are hard at work eliminating abnormal cells,...

OMNICHANNEL ORCHESTRATION IS MORE THAN JUST THE NEXT BEST ACTIONS

Omnichannel orchestration is critical to delivering a customized and relevant experience to each customer. If designed and executed correctly, responsive omnichannel marketing...

The Evolution of Treatment: Use of Anticoagulation in Cancer Patients

Cancer patients face many heightened health risks after their initial diagnosis. While the disease itself is a leading cause of death worldwide,...

Prostate Cancer Awareness – Men’s Health

While Prostate Cancer (PC) Awareness Month is behind us, the impact of this deadly scourge is not – in fact, it’s pervasiveness...

How Data Science & AI Are Impacting the Patient Experience

Tapping into advanced analytics is enabling healthcare providers to reach more patients with improved outcomes The Role of...

Steering Pharma’s Future: An Interview with Axtria’s Prakash Pothamsetti

Underlying shifts are happening in the pharma industry. Artificial intelligence and big data are accelerating the speed at which pharma companies are...

Parkinson’s, autism spectrum disorder, and the gut-brain axis: A role for psychobiotics in ameliorating neurological symptoms from the gut

The need is acute for more safe and effective ways to help patients live more comfortably with chronic neurological conditions like Parkinson’s...

Latest news

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc...

Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market

In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia...

Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities 

After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Sanofi accused of widespread employee email deletion tied to its 2019 recall of Zantac

Following FDA investigations on a contaminant suspected of causing cancer, Zantac, a renowned medication for acid reflux